PL1623977T3 - Związek pośredni stosowany do wytwarzania pioglitazonu - Google Patents
Związek pośredni stosowany do wytwarzania pioglitazonuInfo
- Publication number
- PL1623977T3 PL1623977T3 PL04731028T PL04731028T PL1623977T3 PL 1623977 T3 PL1623977 T3 PL 1623977T3 PL 04731028 T PL04731028 T PL 04731028T PL 04731028 T PL04731028 T PL 04731028T PL 1623977 T3 PL1623977 T3 PL 1623977T3
- Authority
- PL
- Poland
- Prior art keywords
- pioglitazone
- preparation
- intermediate compound
- compound
- Prior art date
Links
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 229960005095 pioglitazone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301075A ES2219180B1 (es) | 2003-05-09 | 2003-05-09 | Compuesto intermedio util para la preparacion de pioglitazona. |
| EP04731028A EP1623977B1 (en) | 2003-05-09 | 2004-05-04 | Intermediate compound which is used for the preparation of pioglitazone |
| PCT/ES2004/070031 WO2004099147A1 (es) | 2003-05-09 | 2004-05-04 | Compuesto intermedio útil para la preparación de pioglitazona |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1623977T3 true PL1623977T3 (pl) | 2008-04-30 |
Family
ID=33427384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL04731028T PL1623977T3 (pl) | 2003-05-09 | 2004-05-04 | Związek pośredni stosowany do wytwarzania pioglitazonu |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7375231B2 (pl) |
| EP (1) | EP1623977B1 (pl) |
| AR (1) | AR044267A1 (pl) |
| AT (1) | ATE377588T1 (pl) |
| CA (1) | CA2525190A1 (pl) |
| DE (1) | DE602004009917T2 (pl) |
| ES (2) | ES2219180B1 (pl) |
| PL (1) | PL1623977T3 (pl) |
| PT (1) | PT1623977E (pl) |
| WO (1) | WO2004099147A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101360736A (zh) * | 2005-11-23 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | L-丙氨酸衍生物 |
| US20090062267A1 (en) * | 2007-01-29 | 2009-03-05 | Astrazeneca Ab | L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| WO2008125811A1 (en) * | 2007-04-11 | 2008-10-23 | Astrazeneca Ab | N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS |
| WO2012177956A1 (en) * | 2011-06-23 | 2012-12-27 | Metabolic Solutions Development Comapny, Llc | Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JPH08325263A (ja) * | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規２−アミノ−３−フェニルプロピオン酸誘導体 |
| JP2000344748A (ja) * | 1999-03-29 | 2000-12-12 | Welfide Corp | ３−芳香族置換プロピオン酸またはアクリル酸化合物 |
| PL363738A1 (pl) * | 2001-04-26 | 2004-11-29 | Leciva A.S. | Sposób wytwarzania pioglitazonu jako środka przeciwcukrzycowego |
-
2003
- 2003-05-09 ES ES200301075A patent/ES2219180B1/es not_active Expired - Fee Related
-
2004
- 2004-05-04 WO PCT/ES2004/070031 patent/WO2004099147A1/es not_active Ceased
- 2004-05-04 DE DE602004009917T patent/DE602004009917T2/de not_active Expired - Fee Related
- 2004-05-04 PT PT04731028T patent/PT1623977E/pt unknown
- 2004-05-04 CA CA002525190A patent/CA2525190A1/en not_active Abandoned
- 2004-05-04 US US10/555,659 patent/US7375231B2/en not_active Expired - Fee Related
- 2004-05-04 ES ES04731028T patent/ES2297415T3/es not_active Expired - Lifetime
- 2004-05-04 EP EP04731028A patent/EP1623977B1/en not_active Expired - Lifetime
- 2004-05-04 PL PL04731028T patent/PL1623977T3/pl unknown
- 2004-05-04 AT AT04731028T patent/ATE377588T1/de not_active IP Right Cessation
- 2004-05-07 AR ARP040101563A patent/AR044267A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1623977E (pt) | 2008-01-22 |
| EP1623977B1 (en) | 2007-11-07 |
| EP1623977A1 (en) | 2006-02-08 |
| US7375231B2 (en) | 2008-05-20 |
| DE602004009917T2 (de) | 2008-08-21 |
| ES2219180A1 (es) | 2004-11-16 |
| ATE377588T1 (de) | 2007-11-15 |
| ES2297415T3 (es) | 2008-05-01 |
| DE602004009917D1 (de) | 2007-12-20 |
| US20070083050A1 (en) | 2007-04-12 |
| WO2004099147A1 (es) | 2004-11-18 |
| AR044267A1 (es) | 2005-09-07 |
| CA2525190A1 (en) | 2004-11-18 |
| ES2219180B1 (es) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1967A (en) | Thiazolidinone compounds as inhibitors of Hyak3 | |
| TWI350831B (en) | Process for the preparation of ring compounds | |
| PL372198A1 (pl) | Związki heteroarylowe użyteczne jako inhibitory GSK-3 | |
| IL173456A0 (en) | Process for the preparation of 4-amino-3-quinolinecarbonitriles | |
| GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
| PL1516540T3 (pl) | Zastosowanie związków z grupy witaminy D | |
| IL172629A0 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
| IL159355A0 (en) | Process for the preparation of nitrile compounds | |
| TWI347945B (en) | Process for the preparation of thiazolopyrimidines | |
| IL174867A0 (en) | Processes for preparation of ziprasidone | |
| PL1623977T3 (pl) | Związek pośredni stosowany do wytwarzania pioglitazonu | |
| IL166591A0 (en) | Preparation of aztreonam | |
| MY136695A (en) | Process for the preparation of alkylaryl compounds | |
| IL165895A0 (en) | Process for the preparation of phenyl pyrazole compounds | |
| ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
| SI1623977T1 (sl) | Vmesna spojina, ki se uporablja za pripravo pioglitazona | |
| PL1656358T3 (pl) | Trwały polimorf mesylanu bifeprunoksu | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| AP1985A (en) | Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof | |
| ITMI20030019A1 (it) | Procedimento per la preparazione di composti mono- | |
| PT1622926E (pt) | Novo processo e intermediários de preparação de compostos 19-nor-esteróides-17-halogéneo | |
| ZA200509495B (en) | Process for the preparation of nicotinaldehydes | |
| IL178960A0 (en) | Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds | |
| GB0317128D0 (en) | Use of antitumoral compounds | |
| HU0300255D0 (en) | Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine |